BUSINESS News 23andMe Lays Off 40% of Staff, Shuts Drug Development Business HS 11/11/2024 Advertisements The genetics company is closing a unit that was once seen as core to its future. Source link Continue Reading Previous Aristocrat to Sell Palarium Mobile Gaming for Up to $820 MillionNext Exxon Says Trump Should Keep U.S. in Paris Climate Pact More Stories BUSINESS News Two top Walmart executives leave company under new CEO John Furner HS 22/05/2026 BUSINESS News Trump said he'd 'remember' companies that didn't apply for tariff refunds. Many of them are anyway HS 22/05/2026 BUSINESS News What the AvalonBay, Equity Residential megamerger means for the apartment industry and rents HS 22/05/2026